Research Papers

25 of 3527 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Lymph node metastases in middle and upper mediastinum of Siewert type II adenocarcinoma: A real-world retrospective stu…
Luo P; Chen X; Yang Y; Zhang R; Kang X; Qin J; Qi X; Li Y.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to…
Yang M; Mao X; Li L; Yang J; Xing H; Jiang C.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Psychometric validation of the Functional Assessment of Cancer Therapy-Endometrial among endometrial cancer patients.
Kim S; Noh JJ; Kim Y; Cho J; Kang D; Lee YY.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in Japan.
Aiba H; Kojima Y; Shimoi T; Sudo K; Yazaki S; Imai T; Yoshida A; Iwata S; Kobayashi E; Kawai A; Arakawa A; Ogawa C; Kimura H; Yonemori K.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening.
Nofal S; Niu J; Resong P; Jin J; Merriman KW; Le X; Katki H; Heymach J; Antonoff MB; Ostrin E; Wu J; Zhang J; Toumazis I.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Survival of the Hmong population diagnosed with colon and rectal cancers in the United States.
Walker MR; Lor K; Lor KB; Vidri RJ; Hampton JM; Maldonado C; Schiefelbein AM; LoConte NK.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high-risk factors in local…
Kamal MV; Damerla RR; Parida P; Rao M; Belle VS; Dikhit PS; Palod A; Gireesh R; Kumar NA.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary.
Harvey S; Stares M; Scott JA; Thottiyil TJV; Conway AM; Haigh R; Brown J; Knowles G; Dasgupta S; Shiu KK; Mitchell C; Barrie C; Cook N; Clive S.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona.
Valencia CI; Wightman P; Morrill KE; Hsu CH; Arif-Tiwari H; Kauffman E; Gachupin FC; Chipollini J; Lee BR; Garcia DO; Batai K.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Incidence of immunotherapy-related hyperprogressive disease (HPD) across HPD definitions and cancer types in observatio…
Kim MJ; Hong SPD; Park Y; Chae YK.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially allevia…
Leroy H; Gadaud N; Bérard E; Klein E; Luquet I; Vial JP; Rieu JB; Lechevalier N; Tavitian S; Leguay T; Largeaud L; Bidet A; Delabesse E; Sarry A; de Grande AC; Récher C; Pigneux A; Bertoli S; Dumas PY.
Cancer Med (Unknown)
Published: 2024
2/6 Transparent
Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis.
Wang W; Wang Y; Zeng W; Xie X; Li C; Zhou Q; Shen L.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival …
Luomala L; Mattila K; Vainio P; Nisén H; Pellinen T; Lohi J; Laajala TD; Järvinen P; Koskenniemi AR; Jaakkola P; Mirtti T.
Cancer Med (Unknown)
Published: 2024
2/6 Transparent
Funding Declared
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced so…
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions.
Tavakkoli A; Beauchamp A; Prasad T; Zhu H; Singal AG; Elmunzer BJ; Kubiliun NM; Kwon RS; Hughes AE; Pruitt SL.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Fertility counselling and fertility preservation among early onset female cancer patients-A Finnish register-based stud…
Melin J; Holopainen E; Savolainen-Peltonen H.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Con…
Zhang M; Chen C; Li G; Koric A; Lee YA; Morgenstern H; Schwartz SM; Sturgis EM; Boffetta P; Hashibe M; Zhang ZF.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Finding a needle in a haystack: The identification of clinical practice guidelines for psychosocial oncology through an…
Bergeron C; Azzi M; Coroiu A; Loiselle CG; Drapeau M; Körner A.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary comp…
Li Y; Zhao J; Zhao Y; Li R; Dong X; Yao X; Xia Z; Xu Y; Li Y.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
What do cancer patients experience of the simultaneous care clinic? Results of a cross-sectional study on patient care …
Galiano A; Feltrin A; Pambuku A; Lo Mauro L; De Toni C; Murgioni S; Soldà C; Maruzzo M; Bergamo F; Brunello A; Zagonel V.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Risk stratification of LA-NPC during chemoradiotherapy based on clinical classification and TVRR.
Tang Q; Mei C; Huang B; Huang R; Kang L; Chen A; Lei N; Deng P; Ying S; Zhang P; Qin Y.
Cancer Med (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarc…
Kaçaroğlu D; Yaylacı S; Gurbuz N.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Somatic mutations in a multigene panel and impact on prognosis based on TP53 status in Chinese HER2-positive patients u…
Xiong M; Wang X; Liu D; Xiu B; Zhang Q; Chi W; Goh CW; Zhang L; Chen M; Ren H; Shao ZM; Yang B; Wu J.
Cancer Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared